Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis - Wikidata - awgldk - TriplyDB

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

http://www.wikidata.org/entity/Q34778143

about

MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma MicroRNAs in Nonalcoholic Fatty Liver Disease Role of microRNAs in Alcohol-Induced Multi-Organ Injury MicroRNAs in fibrosis: opportunities and challenges Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery Epigenetics in liver disease: from biology to therapeutics Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine Genetic predisposition in nonalcoholic fatty liver disease.Genetic variation in long noncoding RNAs and the risk of nonalcoholic fatty liver disease.Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases Circulating RNA molecules as biomarkers in liver disease.Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.Micro-RNA 21 inhibition of SMAD7 enhances fibrogenesis via leptin-mediated NADPH oxidase in experimental and human nonalcoholic steatohepatitis Micro RNAs in the development of non-alcoholic fatty liver disease.Potential epigenetic mechanism in non-alcoholic Fatty liver disease Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer The Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection.Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis.High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model.High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers for Measuring Puberty Onset in Chicken (Gallus gallus).Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH.miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation.Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease Plasma microRNA expression profiles in Chinese patients with rheumatoid arthritis.Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.Circulating microRNAs in nonalcoholic fatty liver disease.Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study.

P2860

Q26750448-896D8101-4E2C-49E3-B3DE-8C0793D8B85E Q26751392-A2EC47E5-06B6-4CE9-9F6A-0DFB5B4EE807 Q26765476-08E6C7EA-01FD-4141-9AEA-531F6CB4A49D Q26766533-4290AA53-64B7-4BA7-9CE0-DDE8182350CC Q26767346-AFD7CAB5-FFDB-4B7D-9A02-72E9A8E3753C Q26774294-8241F74E-AFED-4338-8503-A8B5DBF643D5 Q26776506-C9F95018-C659-411F-A937-6D15789FDFDD Q28067380-AC138014-4995-4872-81A7-2939D3942BBB Q28072402-7643896F-14C1-48BB-81B4-F95F17FA68F4 Q28079271-365691CE-649E-4047-AE84-BA06D6787797 Q28086887-67D2862B-DC64-4853-A174-24BECEA79004 Q30235398-8C72DF5E-1035-4F07-AF15-85C8A08B1385 Q33618518-A551DB92-286F-49EA-9E3E-F6FD3B526AA3 Q33759921-F09E0842-9D6E-4688-AE64-599D59B9F51F Q33807881-E2F1DC1C-8819-447B-A20C-EA2C10B51AC8 Q34391443-88233D11-452E-4A67-A784-DCF023225118 Q34486635-8B08D972-CB02-4727-9554-EB90DACBFEBA Q34626474-7F9459C9-10EC-492B-9661-CA034DBF8296 Q35086412-0BE4BB00-8278-4E3F-A261-0AB564E3AC22 Q35127045-71F57BD9-84B9-4D28-B2BE-902CBC03E9DC Q35380845-114D593A-6D4E-4DA2-9CD8-8787C6C58370 Q35650689-A19CEFF7-2318-45F4-820E-1D697CF71E0B Q35720244-A336F51F-00D9-4AA7-A576-72E1793C58B8 Q35840874-2CCAA894-F885-402F-980D-CEAC6DED52E8 Q35958233-9F37F3F7-E773-4B09-857E-0AC14CDFF313 Q36005098-B7A3F9FA-9CDA-4103-AFDC-C23F92AEB5D7 Q36009702-9465A261-47F7-43D6-9345-17CD575C2913 Q36129673-7E76D520-FC38-4E0D-B17E-102EBC1B07BE Q36220756-27308DE0-8572-41E0-9AC0-8B0E0760BCF7 Q36329460-436DDB84-F97C-438C-B8F0-29716BB0659D Q36504308-05F16E86-7447-4866-B41D-FB777B820EA8 Q36591967-A18C7B8F-04B1-49D2-9222-CFDCC76E30CE Q36597717-A22E8B7A-501A-47EE-82D6-8E4CC828E7B0 Q36618929-EC261787-CC2F-49E7-8D2B-1C375A20E0AF Q36764809-F9000A80-13A5-4FA9-AB43-55EDBA0ABF3C Q36912465-11566728-C37E-46E1-AEF2-ED4F61683F52 Q37046260-9A68BF66-AE66-4B35-98BE-B4D62F188C64 Q37244257-606C49F2-6267-4169-BAF9-8185C5350D8D Q37377220-527D3E59-E53D-4691-A030-08497B4CBF3F Q37384502-FFC75DA9-82A0-45C6-BBF7-414CB3B7B84F

P2860

Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

http://www.wikidata.org/entity/Q34778143

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating microRNA signature ...... ology and disease pathogenesis

@ast

Circulating microRNA signature ...... ology and disease pathogenesis

@en

Circulating microRNA signature ...... ology and disease pathogenesis

@nl

type

label

Circulating microRNA signature ...... ology and disease pathogenesis

@ast

Circulating microRNA signature ...... ology and disease pathogenesis

@en

Circulating microRNA signature ...... ology and disease pathogenesis

@nl

prefLabel

Circulating microRNA signature ...... ology and disease pathogenesis

@ast

Circulating microRNA signature ...... ology and disease pathogenesis

@en

Circulating microRNA signature ...... ology and disease pathogenesis

@nl

P1433

Q34778143-0CE58C6B-3E04-46FC-BE5D-5FA0070AD8BA

P1476

Q34778143-AC28CBC5-6005-4589-B082-00D7D3ED70F9

P2093

Q34778143-0CD6932E-17D0-46EF-BF31-DC9B91965237

Q34778143-34CAA9CD-3013-4B8C-9AF2-5FBF32E8B96E

Q34778143-48B9ED7A-9642-4979-9B8A-35C83EF041B8

Q34778143-4BAAFD94-D8C5-478C-94A2-1E4A01338366

Q34778143-796CCA57-0558-4850-821F-B1C76673D275

Q34778143-7A9F3DED-A522-4503-A543-D2843A21FC94

Q34778143-839D1C45-6D6F-4C89-B911-F7F312227D2B

Q34778143-850F2A53-0CB3-48D9-AB2D-92A518794A2D

Q34778143-973F37AF-BC3C-4280-B5DD-6A6D0E9A45ED

Q34778143-E04D88AA-A953-48C3-BDD6-7A7C428A6157

P2860

Q34778143-038C7EDC-7188-45B6-9882-23A85F77DAB3

Q34778143-08EF0679-D98E-4519-873D-39AD5DA5808F

Q34778143-0B1648FF-F78B-444D-91A8-050946999904

Q34778143-11F2EC38-C28A-4A1B-B6B4-1914965FE49A

Q34778143-39A8FF9D-6812-4FB3-B8F0-99B2DC30F94F

Q34778143-44158594-EACF-4795-B4EE-5143078C0867

Q34778143-472888CF-E1AD-4FE8-801F-DA13194A0C82

Q34778143-5388EC4D-1B28-4EA3-AD39-E218334CB0A2

Q34778143-6002BE9B-0325-4C38-B42F-234B439A609D

Q34778143-6EC8DFC7-B6EF-4D50-88AC-93978F60F9FD

P304

Q34778143-D06217D6-2141-4D2E-A3E5-E9AC51AD1628

P31

Q34778143-D0029E8E-7C5F-4826-8869-24AF7C6C8227

P356

Q34778143-B3C32F33-F63B-42BF-A0B2-2C4E40E0C8A1

P407

Q34778143-93623698-1764-459D-B4C8-176642545044

P433

Q34778143-F780B69E-A7AB-420A-B243-0C963F728D26

P478

Q34778143-F8946021-321C-4B61-A8A6-68941F39731C

P577

Q34778143-AA12F879-D87B-4745-AA70-DD7D30090AA2

P698

Q34778143-7E478265-0B1E-4067-997A-3F6CF4197582

P921

Q34778143-D7124711-4FE4-4BAC-81F6-AE0E5C1C5C6F

P932

Q34778143-8D4382E1-3C93-406F-873A-62E837C65CDF

P356

GUTJNL-2014-306996

P1433

P1476

Circulating microRNA signature ...... ology and disease pathogenesis

@en

P2093

Arun J Sanyal

http://www.w3.org/2001/XMLSchema#string

Carlos J Pirola

http://www.w3.org/2001/XMLSchema#string

Diego Flichman

http://www.w3.org/2001/XMLSchema#string

Faridodin Mirshahi

http://www.w3.org/2001/XMLSchema#string

Gustavo O Castaño

http://www.w3.org/2001/XMLSchema#string

Julio San Martino

http://www.w3.org/2001/XMLSchema#string

María Mora Gonzalez Lopez Ledesma

http://www.w3.org/2001/XMLSchema#string

Pablo Mallardi

http://www.w3.org/2001/XMLSchema#string

Silvia Sookoian

http://www.w3.org/2001/XMLSchema#string

Tomas Fernández Gianotti

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

A miR-19 regulon that controls NF-κB signaling

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

microRNA-122 stimulates translation of hepatitis C virus RNA

Most mammalian mRNAs are conserved targets of microRNAs

Circulating microRNAs, potential biomarkers for drug-induced liver injury

miR-375 maintains normal pancreatic alpha- and beta-cell mass

MicroRNAs in vascular and metabolic disease

Widespread changes in protein synthesis induced by microRNAs

P304

800-812

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2014-306996

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24973316

http://www.w3.org/2001/XMLSchema#string

P921

P932

4277726

http://www.w3.org/2001/XMLSchema#string